Viewing Study NCT00496392


Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2026-02-02 @ 5:17 PM
Study NCT ID: NCT00496392
Status: COMPLETED
Last Update Posted: 2012-05-07
First Post: 2007-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)
Sponsor: Nycomed
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breakthrough pain in patients with cancer View